Skip to main content
Back to RA Capital Management

RA Capital Management's Health Care Portfolio

Browse 49 Health Care companies funded by RA Capital Management. See funding amounts, founder contacts, and investment details.

Health Care Companies
49
Total Funding in Health Care
$5.2B

Health Care Portfolio Companies (49)

Export
BiotechnologyHealth CareMedicalTherapeutics

Secretome Therapeutics is a clinical-stage cell therapy company that develops therapies for rare cardiac diseases.

Dallas, United States
May 2026
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Cambridge, United States
May 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.

Durham, United States
April 2026
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalNeurosciencePharmaceutical

Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.

Redmond, United States
April 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.

Foster City, United States
April 2026
$48.0M
Convertible Note

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.

Copenhagen, Denmark
April 2026
$135.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsHealth CareMedical

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

Charlestown, United States
March 2026
$240.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.

Cambridge, United States
March 2026
$40.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

Terrestrial Bio engages in developing biomedical innovations with a focus on improving access to vaccines.

Cambridge, United States
March 2026
$50.0M
Series C

Founder Contacts

19,000+ verified contacts

Health CareMedicalTherapeutics

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

South San Francisco, United States
September 2025
$125.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeuroscience

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

Boston, United States
September 2025
$25.0M
Series B

Founder Contacts

19,000+ verified contacts

Health CareHospitalPersonal Health

Commons Clinic is a multi-specialty clinic offering minimally-invasive surgical and conservative musculoskeletal care.

Los Angeles, United States
June 2025
$26.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.

Boston, United States
April 2025
$59.2M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.

Cambridge, United States
April 2025
$9.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.

San Mateo, United States
March 2025
$35.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Bambusa Therapeutics operates as biotechnology company.

Boston, United States
February 2025
$90.0M
Series A

Founder Contacts

19,000+ verified contacts

Health CareMedicalNeuroscienceWellness

We provide neurodegenerative disease patients with expert MDs and 24/7 wrap around care, no matter where you live in the US

Chicago, United States
November 2024
$25.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeuroscience

Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.

South San Francisco, United States
November 2024
$101.0M
Series A

Founder Contacts

19,000+ verified contacts

Clinical TrialsHealth CareMedical Device

Innoventric, a start-up company from Ness-Ziona, Israel, develops the unique Trillium technology

Ness Ziona, Israel
October 2024
$28.5M
Series B

Founder Contacts

19,000+ verified contacts

Health CareMedicalPharmaceutical

Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.

Cambridge, United States
September 2024
$40.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Carmel, United States
August 2024
$63.5M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Seattle, United States
August 2024
$144.0M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

Philadelphia, United States
June 2024
$51.4M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

San Mateo, United States
May 2024
$182.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsTherapeutics

SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.

Charlestown, United States
April 2024
$48.0M
Series D

Founder Contacts

19,000+ verified contacts

Health CareMedicalWellness

Ventricle Health offers evidence-based therapy, remote patient monitoring, patient education, and advocacy services for cardiac care.

Greensboro, United States
October 2023
$8.0M
Seed

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife Science

ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.

San Francisco, United States
August 2023
$4.0M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Expansion Therapeutics is a biotechnology company focusing on developing transformative oral medicines for severe RNA-mediated diseases.

San Diego, United States
January 2023
$6.9M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceMedicalPharmaceuticalPrecision Medicine

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Cambridge, United States
January 2026
$305.0M
Series F

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsManufacturing

Nature’s Toolbox is a biotechnology company that provides a proprietary host-independent biological manufacturing and development platform.

Rio Rancho, United States
December 2025
$10.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Health CareMedicalTherapeutics

Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.

Boston, United States
January 2026
$103.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife Science

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

Palo Alto, United States
February 2026
$125.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalOncologyTherapeutics

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

Redwood City, United States
February 2026
$50.1M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncologyTherapeutics

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Waltham, United States
February 2026
$40.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

Westlake Village, United States
February 2026
$130.0M
Series D

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.

San Carlos, United States
January 2026
$632.5M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.

San Carlos, United States
January 2026
$1.6M
Grant

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.

Shanghai, China
January 2026
$287.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

Philadelphia, United States
January 2026
$135.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Health CareTherapeutics

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

Waltham, United States
December 2025
$45.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

San Francisco, United States
December 2025
$60.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Cambridge, United States
December 2025
$402.5M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

GeneticsHealth CareMedical

Sidera Bio harness human genetics, that helps in transformative medicines for patients.

Copenhagen, Denmark
December 2025
$109.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

Boston, United States
December 2025
$350.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Belite Bio is a clinical stage biopharmaceutical drug development company.

San Diego, United States
December 2025
$350.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsOncologyPersonal Health

Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.

South San Francisco, United States
November 2025
$75.0M
Corporate Round

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsNeurosciencePharmaceutical

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

New Haven, United States
November 2025
$200.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.

Cambridge, United States
October 2025
$3.6M
Grant

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Cambridge, United States
October 2025
$197.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Explore RA Capital Management's Full Portfolio

View all companies funded by RA Capital Management across every industry and funding stage.

View Full RA Capital Management Portfolio